IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Aristo Bio-Tech and Lifescience IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Vadodara and caters to Chemical - Pesticides sector. Beeline Capital Advisors Private is the merchant banker of Aristo Bio-Tech and Lifescience IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th April 2022.
Aristo Bio-Tech and Lifescience IPO open date is 16th January 2023 and close date is 19th January 2023. IPO Allotment Date is 25th January 2023 and Listing date is 30th January 2023.Aristo Bio-Tech and Lifescience IPO size is Rs 13.05 Cr. crores with IPO price of Rs 72.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Beeline Capital Advisors Private Limited is the book-running lead manager of the Aristo Bio-Tech and Lifescience IPO. Link Intime India Private Limited is the Registrar and Market Maker is [●] for Aristo Bio-Tech and Lifescience IPO.
Aristo Bio-Tech and Lifescience IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Aristo Bio-Tech and Lifescience IPO, based in Vadodara, operates in the Chemical - Pesticides sector with a focus on Manufacturing of Pesticides. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Aristo Bio-Tech and Lifescience IPO size is ₹ 13.05 Cr. Crores with fresh issue size of Rs 13.05 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Aristo Bio-Tech and Lifescience IPO is expected to be 25th January 2023, after the finalization of basis of allotment. Investors can check Aristo Bio-Tech and Lifescience IPO allotment status on the registrars website, Link Intime India Private Limited. Aristo Bio-Tech and Lifescience IPO refund dates are 30th November -0001.
Aristo Bio-Tech and Lifescience IPO is expected to be listed on 30th January 2023.
The upper price band for the Aristo Bio-Tech and Lifescience IPO is set at ₹ 72.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Aristo Bio-Tech and Lifescience IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Aristo Bio-Tech and Lifescience IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 19th January 2023. After submission, funds are blocked until the basis of allotment of Aristo Bio-Tech and Lifescience IPO is finalised.
The merchant banker for Aristo Bio-Tech and Lifescience IPO is Beeline Capital Advisors Private Limited . Beeline Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Aristo Bio-Tech and Lifescience IPO RHP for further details.
The registrar for Aristo Bio-Tech and Lifescience IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Aristo Bio-Tech and Lifescience IPO through their official website or helpline.
Aristo Bio-Tech and Lifescience IPO was subscribed 217.72 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 13.05 Cr.
Avg IPO Size (Sector Based)
:
₹ 29.91 Cr.
Sector: Chemical - Pesticides
SME IPO so far:
5
Merchant Banker:
Beeline Capital
SME IPO by BRLM so far:
47
City:
Vadodara
SME IPO so far:
22
Revenue (annualised):
₹ 303.12 cr.
PE
Ratio:
9.46x
Average Sector PE Ratio: 14.30x
Aristo Bio-Tech and Lifescience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Aristo Bio-Tech and Lifescience Financial Review Page
Merchant Banker(s) of Aristo Bio-Tech and Lifescience IPO: Beeline Capital Advisors Private Limited
Aristo Bio-Tech and Lifescience IPO subscription was 217.72 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Aristo Bio-Tech and Lifescience IPO listed at a listing price of 80.00 against the offer price of 72.00.
The current market price of Aristo Bio-Tech and Lifescience is 133.60.
Why Us?
